Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LYPRESSIN Cause Activated partial thromboplastin time prolonged? 26 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 26 reports of Activated partial thromboplastin time prolonged have been filed in association with LYPRESSIN. This represents 40.6% of all adverse event reports for LYPRESSIN.

26
Reports of Activated partial thromboplastin time prolonged with LYPRESSIN
40.6%
of all LYPRESSIN reports
26
Deaths
25
Hospitalizations

How Dangerous Is Activated partial thromboplastin time prolonged From LYPRESSIN?

Of the 26 reports, 26 (100.0%) resulted in death, 25 (96.2%) required hospitalization, and 25 (96.2%) were considered life-threatening.

Is Activated partial thromboplastin time prolonged Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LYPRESSIN. However, 26 reports have been filed with the FAERS database.

What Other Side Effects Does LYPRESSIN Cause?

Abdominal distension (51) Vomiting (51) Abdominal pain (50) Appendicitis (50) Ascites (50) Condition aggravated (50) Hyponatraemia (50) Off label use (50) Sepsis (50) Somnolence (50)

What Other Drugs Cause Activated partial thromboplastin time prolonged?

DABIGATRAN ETEXILATE (264) HEPARIN (225) RIVAROXABAN (163) WARFARIN (146) ACETAMINOPHEN (119) ALLOPURINOL (110) AMIODARONE (99) METRONIDAZOLE (98) SIMVASTATIN (94) DARBEPOETIN ALFA (93)

Related Pages

LYPRESSIN Full Profile All Activated partial thromboplastin time prolonged Reports All Drugs Causing Activated partial thromboplastin time prolonged LYPRESSIN Demographics